Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord mesenchymal stem cells for children with spastic cerebral palsy
IRCT20110628006907N14Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of allogeneic umbilical cord-derived mesenchymal stem cells in cerebral palsy (CP) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Gross Motor Function Measurement-66, Gross Motor Function Classification System and 4 more. Started Apr 2020; status: completed.
02
Drugs
allogeneic umbilical cord-derived mesenchymal stem cells
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on IRCT20110628006907N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110628006907N14.